Crossmark Global Holdings’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-11,300
Closed -$452K 1279
2024
Q2
$452K Buy
11,300
+275
+2% +$11K 0.01% 879
2024
Q1
$484K Sell
11,025
-194
-2% -$8.52K 0.01% 882
2023
Q4
$694K Sell
11,219
-194
-2% -$12K 0.01% 719
2023
Q3
$548K Buy
11,413
+168
+1% +$8.07K 0.01% 784
2023
Q2
$684K Sell
11,245
-259
-2% -$15.8K 0.01% 714
2023
Q1
$432K Sell
11,504
-107
-0.9% -$4.02K 0.01% 892
2022
Q4
$325K Buy
11,611
+330
+3% +$9.24K 0.01% 986
2022
Q3
$317K Buy
11,281
+129
+1% +$3.63K 0.01% 968
2022
Q2
$387K Buy
+11,152
New +$387K 0.01% 924